进展期胃癌术后应用多西他赛联合卡培他滨化疗及同步放疗的疗效观察
目的：探讨进展期胃癌根治术后予以多西他赛联合卡培他滨化疗及同步放疗的疗效。方法：选取2013年10月—2015年3月湖北省公安县人民医院收治的进展期胃癌根治术后患者76例作为研究对象,以随机数字表法分为观察组和对照组各38例。观察组患者采用多西他赛联合卡培他滨化疗并同步放疗;对照组患者采用多西他赛＋奥沙利铂＋氟尿嘧啶/醛氢叶酸的单纯化疗方案,比较2组患者的1、3年生存率及不良反应发生情况。结果：观察组患者1、3年生存率分别为84.21%（32/38）、55.26%（21/38）,对照组分别为63.16%（24/38）、28.95%（11/38）,2组的差异有统计学意义（P〈0.05）;观察组患...
Saved in:
| Published in | 中国医院用药评价与分析 Vol. 16; no. 8; pp. 1055 - 1057 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
湖北省公安县人民医院普外科,湖北公安,434300
2016
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1672-2124 |
| DOI | 10.14009/j.issn.1672-2124.2016.08.018 |
Cover
| Abstract | 目的：探讨进展期胃癌根治术后予以多西他赛联合卡培他滨化疗及同步放疗的疗效。方法：选取2013年10月—2015年3月湖北省公安县人民医院收治的进展期胃癌根治术后患者76例作为研究对象,以随机数字表法分为观察组和对照组各38例。观察组患者采用多西他赛联合卡培他滨化疗并同步放疗;对照组患者采用多西他赛＋奥沙利铂＋氟尿嘧啶/醛氢叶酸的单纯化疗方案,比较2组患者的1、3年生存率及不良反应发生情况。结果：观察组患者1、3年生存率分别为84.21%（32/38）、55.26%（21/38）,对照组分别为63.16%（24/38）、28.95%（11/38）,2组的差异有统计学意义（P〈0.05）;观察组患者的不良反应发生率为76.32%（29/38）,对照组为71.05%（27/38）,2组的差异无统计学意义（P〉0.05）。结论：进展期胃癌根治术后采用多西他赛联合卡培他滨化疗并同步放疗与术后单纯化疗相比,提高患者的生存率。 |
|---|---|
| AbstractList | R979.1; 目的：探讨进展期胃癌根治术后予以多西他赛联合卡培他滨化疗及同步放疗的疗效。方法：选取2013年10月—2015年3月湖北省公安县人民医院收治的进展期胃癌根治术后患者76例作为研究对象，以随机数字表法分为观察组和对照组各38例。观察组患者采用多西他赛联合卡培他滨化疗并同步放疗；对照组患者采用多西他赛＋奥沙利铂＋氟尿嘧啶／醛氢叶酸的单纯化疗方案，比较2组患者的1、3年生存率及不良反应发生情况。结果：观察组患者1、3年生存率分别为84.21％（32／38）、55.26％（21／38），对照组分别为63.16％（24／38）、28.95％（11／38），2组的差异有统计学意义（P＜0.05）；观察组患者的不良反应发生率为76.32％（29／38），对照组为71.05％（27／38），2组的差异无统计学意义（P＞0.05）。结论：进展期胃癌根治术后采用多西他赛联合卡培他滨化疗并同步放疗与术后单纯化疗相比，提高患者的生存率。 目的：探讨进展期胃癌根治术后予以多西他赛联合卡培他滨化疗及同步放疗的疗效。方法：选取2013年10月—2015年3月湖北省公安县人民医院收治的进展期胃癌根治术后患者76例作为研究对象,以随机数字表法分为观察组和对照组各38例。观察组患者采用多西他赛联合卡培他滨化疗并同步放疗;对照组患者采用多西他赛＋奥沙利铂＋氟尿嘧啶/醛氢叶酸的单纯化疗方案,比较2组患者的1、3年生存率及不良反应发生情况。结果：观察组患者1、3年生存率分别为84.21%（32/38）、55.26%（21/38）,对照组分别为63.16%（24/38）、28.95%（11/38）,2组的差异有统计学意义（P〈0.05）;观察组患者的不良反应发生率为76.32%（29/38）,对照组为71.05%（27/38）,2组的差异无统计学意义（P〉0.05）。结论：进展期胃癌根治术后采用多西他赛联合卡培他滨化疗并同步放疗与术后单纯化疗相比,提高患者的生存率。 |
| Abstract_FL | OBJECTIVE:To probe into the efficacy of docetaxel ( TXT) combined with capecitabine chemotherapy and concurrent radiochemotherapy in advanced gastric cancer after surgery.METHODS: 76 patients with advanced gastric cancer admitted into Gongan County People's Hospital of Hubei Provence from Oct.2013 to Mar.2015 were selected to be divided into observation group and control group via the random number table, with 38 cases in each. The observation group were treated with TXT combined with capecitabine chemotherapy and concurrent radiotherapy;while the control group received TXT and oxaliplatin ( L-OHP ) + fluorouracil ( 5-FU )/leucovorin ( CF ) chemotherapy.1-year and 3-year survival rate, incidence of adverse drug reactions were compared between two groups.RESULTS: 1-year and 3-year survival rate of observation group were 84.21% ( 32/38 ) and 55.26%(21/38), and control group were 63.16% (24/38) and 28.95% (11/38), with statistically significant difference ( P<0.05 ) .The incidence of adverse drug reactions of observation group was 76.32%( 29/38 ) , and control group was 71.05%(27/38), the difference was not statistically significant( P>0.05).CONCLUSIONS: Compared with single chemotherapy, TXT combined with capecitabine chemotherapy and concurrent radiochemotherapy in advanced gastric cancer after surgery is more effective, which can improve the survival rate of patients. |
| Author | 郭鹏 陈金芳 黄巍 刘平后 |
| AuthorAffiliation | 湖北省公安县人民医院普外科,湖北公安434300 |
| AuthorAffiliation_xml | – name: 湖北省公安县人民医院普外科,湖北公安,434300 |
| Author_FL | GUO Peng CHEN Jinfang HUANG Wei LIU Pinghou |
| Author_FL_xml | – sequence: 1 fullname: GUO Peng – sequence: 2 fullname: CHEN Jinfang – sequence: 3 fullname: HUANG Wei – sequence: 4 fullname: LIU Pinghou |
| Author_xml | – sequence: 1 fullname: 郭鹏 陈金芳 黄巍 刘平后 |
| BookMark | eNo9kE9LAmEQxt-DQWZ-iaBbu807-_8Y0j8QungN2XV3baVWc4myW9lBwsqDGqkgQZKXkA4dSsgv07u7H6NXjOYwwzz85hl4VkjCL_sOIesURCoDGJsl0QsCX6SqhgJSlEUEqoqgi0D1BEn-68skHQSeBahogCjJSXIYz_rsvRMOhnG9Hj01w8GEte7ZVztqj9lLLx7Nfqbd-KMfX7VZq8HuntnwkyvhdMya3aj7yB5uWasZvo3C9jdfo94N72GnEb9es8lwlSy55nHgpP9miuR2tnOZPSF7sLuf2coKBVXWBQttAy0ZqQOaq4AtOxpSGw2J2jKi5YJFHVtyKCiWBIYi6WCqoKlYoJqpo6JIKbKxsD03fdf0i_lS-azq84f5y2KNV6VUcy_mkYDOA-H42gIvHJX94qnHDypV78Ss1vKqNgcAdekXvQqG_Q |
| ClassificationCodes | R979.1 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.14009/j.issn.1672-2124.2016.08.018 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Observation on Efficacy of Docetaxel Combined with Capecitabine Chemotherapy and Concurrent Radiochemotherapy in Advanced Gastric Cancer After Surgery |
| DocumentTitle_FL | Observation on Efficacy of Docetaxel Combined with Capecitabine Chemotherapy and Concurrent Radiochemotherapy in Advanced Gastric Cancer After Surgery |
| EndPage | 1057 |
| ExternalDocumentID | zgyyyypjyfx201608018 670183028 |
| GroupedDBID | 2RA 92L ALMA_UNASSIGNED_HOLDINGS CDYEO CQIGP W91 ~WA 2B. 4A8 92I 93N ABDBF ACUHS EOJEC OBODZ PSX TCJ TUS |
| ID | FETCH-LOGICAL-c648-b2d92b421e07f50d4e721d2931d422bf0b1ed3e105b3095380a60762c17a82553 |
| ISSN | 1672-2124 |
| IngestDate | Thu May 29 04:11:27 EDT 2025 Wed Feb 14 10:15:42 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 8 |
| Keywords | 卡培他滨 同步放化疗 进展期胃癌 多西他赛 Capecitabine Concurrent chemoradiotherapy Docetaxel Tolerance 耐受性 Advanced gastric cancer |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c648-b2d92b421e07f50d4e721d2931d422bf0b1ed3e105b3095380a60762c17a82553 |
| Notes | OBJECTIVE ：To probe into the efficacy of docetaxel （TXT） combined with capecitabine chemotherapy and concurrent radiochemotherapy in advanced gastric cancer after surgery. METHODS： 76 patients with advanced gastric cancer admitted into Gongan County People＇s Hospital of Hubei Provence from Oct. 2013 to Mar. 2015 were selected to be divided into observation group and control group via the random number table, with 38 cases in each. The observation group were treated with TXT combined with capecitabine chemotherapy and concurrent radiotherapy; while the control group received TXT and oxaliplatin （L-OHP） ＋ fluorouracil （5-FU）/leucovorin （CF） chemotherapy. 1-year and 3-year survival rate, incidence of adverse drug reactions were compared between two groups. RESULTS： 1-year and 3-year survival rate of observation group were 84.21% （32/38） and 55.26% （21/38）, and control group were 63.16% （24/38） and 28.95% （11/38）, with statistically significant difference （P 〈 0.05 ）. The incidence of adverse drug reactions of ob |
| PageCount | 3 |
| ParticipantIDs | wanfang_journals_zgyyyypjyfx201608018 chongqing_primary_670183028 |
| PublicationCentury | 2000 |
| PublicationDate | 2016 |
| PublicationDateYYYYMMDD | 2016-01-01 |
| PublicationDate_xml | – year: 2016 text: 2016 |
| PublicationDecade | 2010 |
| PublicationTitle | 中国医院用药评价与分析 |
| PublicationTitleAlternate | Evaluation and Analysis of Drug-use in Hospitals of China |
| PublicationYear | 2016 |
| Publisher | 湖北省公安县人民医院普外科,湖北公安,434300 |
| Publisher_xml | – name: 湖北省公安县人民医院普外科,湖北公安,434300 |
| SSID | ssib025702234 ssib017477209 ssib001103637 ssib051368574 ssib000405437 ssib001215202 ssib036441963 ssib006563103 ssib057928707 |
| Score | 2.0476568 |
| Snippet | 目的：探讨进展期胃癌根治术后予以多西他赛联合卡培他滨化疗及同步放疗的疗效。方法：选取2013年10月—2015年3月湖北省公安县人民医院收治的进展期胃癌根治术后患者76例作为... R979.1; 目的：探讨进展期胃癌根治术后予以多西他赛联合卡培他滨化疗及同步放疗的疗效。方法：选取2013年10月—2015年3月湖北省公安县人民医院收治的进展期胃癌根治术后患... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 1055 |
| SubjectTerms | 卡培他滨 同步放化疗 多西他赛 耐受性 进展期胃癌 |
| Title | 进展期胃癌术后应用多西他赛联合卡培他滨化疗及同步放疗的疗效观察 |
| URI | http://lib.cqvip.com/qk/86765X/201608/670183028.html https://d.wanfangdata.com.cn/periodical/zgyyyypjyfx201608018 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVCAB databaseName: Nutrition and Food Sciences Database issn: 1672-2124 databaseCode: DYU dateStart: 20150101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.cabidigitallibrary.org/product/zd omitProxy: true ssIdentifier: ssib001215202 providerName: CAB International – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate issn: 1672-2124 databaseCode: ABDBF dateStart: 20151101 customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn omitProxy: true ssIdentifier: ssib057928707 providerName: EBSCOhost |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9RAFG9wSYwXo1EjooSDcyz2a9qZY7vbhpjoCRI8mM1224V4WFAhEW6KB2JQOSwYgYSYSORiiAcPSiL_jN3dP8P3Xru7QyAGJZtJ-zrzPn6v23lv6bzRtLtGQ5ophKF6Giep7jic6yJJuO7yWsJxK4JajGuHHzx0J6ed-zN8ZqjElbeWlhbjifrKmetK_serQAO_4irZf_BsnykQ4Bj8Cy14GNpz-ZiFggURkwELOQtMJjkLXSbLTEZ4Sdj4CT0mJRPl4pIfYWdpMBHSKJ9Jh_o4zBdI8R0mfRzuc2QeOiwImHRJFidZwNmkUTkfGiUqzDeJErFAKqNcPMg5gw5I8bCVHlEiJvweH9LQr6BcVBU4hEpnD7USjkJx0V6UDqp6TFikPKBx4k1F0kQg25CUDyqFJqBVKBEZ31LMF2QIoQctiiNDAq_gk4MGQgWZJkMm-__vQX6AN4qSiIGI1CvoA0FdQJhJknwW2GoXECQIVRAnKoMrJFAShMA2sPsOVH-yydeS0teLQJeEdQ56Dl8Z3YYUgKlMYIVMSKKEPU_7-MHhBil5GimXDsLejULu9Mkiq3yW3FPirDKuMjYMZTZ0PUuH2MY5MV26ymNBKHMfbrWqxFG4gfSZczTMGpImaZQx0ZeBr1m6VE63mJBPlkFfmV2Gv4Uny40X2BESHVNc0IYtDwLMkjbsB5UgUvIUyESUuBtiXNtVz3E3Z6XuHSQ1uN9e7xyydEg6B3XtbEwa5KBOHTdx24ZB3sQ9ie8L0EZOPXMuaqxn7L2_mYo1Xebmm7NPIVKlhYPNRq05q8S4U1e0y0VyOu7nT5qr2tDK3DXtcfd4J_u22d7d666udj6ut3cPs4132c9Wp3WQfd7u7h__Ptrqft_pvmxlG2vZ20_Z3g-gtI8OsvWtztaH7P2bbGO9_XW_3foFp53t19C2N9e6X15lh3vXtakonCpP6sWmLHrddYQeW4m0YscyU8NrcCNxUs8yE8gZzMSxrLhhxGaa2Ck4P7axlKUwaq4BAVfd9GrC4ty-oZWa8830pjYujaThxIa0DKqw5QmjzpOUO1YjlnZDihFttI9MdSGvvVN1PcDMhqRoRGMFVtXiify8etY9cuuc_Ua1S3ic_7p6WystPltK70C-sRiPFXfXGGTcj6b_AH8r6hk |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%BF%9B%E5%B1%95%E6%9C%9F%E8%83%83%E7%99%8C%E6%9C%AF%E5%90%8E%E5%BA%94%E7%94%A8%E5%A4%9A%E8%A5%BF%E4%BB%96%E8%B5%9B%E8%81%94%E5%90%88%E5%8D%A1%E5%9F%B9%E4%BB%96%E6%BB%A8%E5%8C%96%E7%96%97%E5%8F%8A%E5%90%8C%E6%AD%A5%E6%94%BE%E7%96%97%E7%9A%84%E7%96%97%E6%95%88%E8%A7%82%E5%AF%9F&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E9%99%A2%E7%94%A8%E8%8D%AF%E8%AF%84%E4%BB%B7%E4%B8%8E%E5%88%86%E6%9E%90&rft.au=%E9%83%AD%E9%B9%8F&rft.au=%E9%99%88%E9%87%91%E8%8A%B3&rft.au=%E9%BB%84%E5%B7%8D&rft.au=%E5%88%98%E5%B9%B3%E5%90%8E&rft.date=2016&rft.pub=%E6%B9%96%E5%8C%97%E7%9C%81%E5%85%AC%E5%AE%89%E5%8E%BF%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E6%99%AE%E5%A4%96%E7%A7%91%2C%E6%B9%96%E5%8C%97%E5%85%AC%E5%AE%89%2C434300&rft.issn=1672-2124&rft.volume=16&rft.issue=8&rft.spage=1055&rft.epage=1057&rft_id=info:doi/10.14009%2Fj.issn.1672-2124.2016.08.018&rft.externalDocID=zgyyyypjyfx201608018 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86765X%2F86765X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyyyypjyfx%2Fzgyyyypjyfx.jpg |